Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
Data spans seven presentations across both solid tumors and hematologic malignancies, providing…
Resolution Therapeutics congratulates University of Edinburgh on positive 4-year MATCH trial data on RMT in liver cirrhosis
Four-year follow-up data from the University of Edinburgh’s MATCH study, led by…
STL’s subsidiary announces supply agreement valued over $1Bn with a Hyperscaler for AI-Ready Data Center build-outs
MUMBAI, India, May 22, 2026 /PRNewswire/ -- Sterlite Technologies Limited ("STL") (NSE: STLTECH),…
Relativity Adds Collection of Claude Enterprise Data with Claude Compliance API Integration
News Summary:Relativity integrates the Claude Compliance API to enable the collection of…
Why Data Analytics Projects Fail Without Business Alignment
PRINCETON, N.J., May 21, 2026 (GLOBE NEWSWIRE) -- Enterprises have poured significant…
THE AI REALITY CHECK: DRUID AI PRODUCTION DATA REVEALS THE GAP BETWEEN AI HYPE AND ENTERPRISE ADOPTION
The first in an annual series, the report examines real-world outcomes of…
Amphiform Raises $5.5M Led by General Catalyst and Main Object to Solve Energy Bottlenecks for Data Centres, Space and Defence
OXFORD, United Kingdom and SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) --…
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreichs Ataxia on Monday, May 18, 2026
May 17, 2026 16:00 ET | Source: Design Therapeutics, Inc. CARLSBAD, Calif.,…
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto in metastatic hormone-sensitive prostate cancer
More durable, deeper PSA response in patients treated with Pluvicto plus standard…
Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction
Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to…
